<html>
<head>PUBMED IDs for PSMB7</head>
<body bgcolor='#C5F0F2'><h1>PSMB7</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17521679/'>Tissue specific increase of the catalytic subunits of the 26S proteasome by indirect antioxidant dithiolethione in mice: enhanced activity for degradation of abnormal protein.</a> May 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18565852/'>Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein.</a> June 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20010949/'>PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer.</a> March 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21289309/'>RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5.</a> June 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/26936520/'>Regulation of global gene expression and cell proliferation by APP.</a> January 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27659694/'>Expression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancers.</a> September 24  2016<br></body></html>
